Literature DB >> 26988081

Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases.

Gianvincenzo Sparacia1, Judith A Gadde2, Alberto Iaia2, Benedetta Sparacia3, Massimo Midiri4.   

Abstract

OBJECTIVES: The purpose of our study was to evaluate whether peritumoural perfusion weighted and proton spectroscopic magnetic resonance imaging can be used in differentiating between primary gliomas and solitary metastases.
METHODS: Ten low-grade gliomas, eight high-grade gliomas and 10 metastases were prospectively evaluated with magnetic resonance imaging, dynamic susceptibility contrast enhanced perfusion imaging and single-voxel proton magnetic resonance spectroscopy before surgical resection or stereotactic biopsy. Maximal relative cerebral blood volume values were calculated drawing three regions of interest of 2 cm(2) in the non-enhancing peritumoural areas. Maximal relative cerebral blood volume values were normalised to that of contralateral normal-appearing white matter. Maximal choline/creatine ratios were calculated from three voxels of 10 cm(3) placed in the peritumoural areas defined as non-enhancing peritumoural white matter surrounding the tumour. The tumour grade presumed with these values was compared to histopathological grading. Differences in the study parameters between groups were assessed using the Mann-Whitney test. A receiver operating characteristic analysis was performed to determine cut-off values.
RESULTS: A clear relative cerebral blood volume cut-off value of 1.88 was detected for differentiating low-grade gliomas from high-grade gliomas. A clear relative cerebral blood volume cut-off value of 1.20 was detected for differentiation of metastases from gliomas. The differences in the choline/creatine ratios in the peritumoural regions of high-grade gliomas and of solitary metastasis were statistically significant (P < 0.001) but a clear cut-off value was not found.
CONCLUSION: Our preliminary data support the hypothesis that peritumoural perfusion-weighted imaging can assist in preoperative differentiation between a glioma and a solitary metastasis.
© The Author(s) 2016.

Entities:  

Keywords:  Brain glioma; brain metastases; magnetic resonance spectroscopy; perfusion weighted magnetic resonance imaging

Mesh:

Year:  2016        PMID: 26988081      PMCID: PMC4977921          DOI: 10.1177/1971400916638358

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  27 in total

1.  High-Grade Cerebral Glioma Characterization: Usefulness of MR Spectroscopy and Perfusion Imaging Associated Evaluation.

Authors:  I Aprile; C Torni; P Fiaschini; M Muti
Journal:  Neuroradiol J       Date:  2012-03-01

2.  Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.

Authors:  M Vittoria Spampinato; J Keith Smith; Lester Kwock; Matthew Ewend; John D Grimme; Daniel L A Camacho; Mauricio Castillo
Journal:  AJR Am J Roentgenol       Date:  2007-01       Impact factor: 3.959

Review 3.  Treatment of malignant glioma: a problem beyond the margins of resection.

Authors:  A Giese; M Westphal
Journal:  J Cancer Res Clin Oncol       Date:  2001-04       Impact factor: 4.553

4.  Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas.

Authors:  Stella Blasel; Alina Jurcoane; Kea Franz; Gerald Morawe; Stefanie Pellikan; Elke Hattingen
Journal:  Acta Neurochir (Wien)       Date:  2010-08-27       Impact factor: 2.216

5.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

6.  Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema.

Authors:  R Ricci; A Bacci; V Tugnoli; S Battaglia; M Maffei; R Agati; M Leonardi
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

7.  1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study.

Authors:  P E Sijens; M V Knopp; A Brunetti; K Wicklow; B Alfano; P Bachert; J A Sanders; A E Stillman; H Kett; R Sauter
Journal:  Magn Reson Med       Date:  1995-06       Impact factor: 4.668

8.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.

Authors:  H Bruhn; J Frahm; M L Gyngell; K D Merboldt; W Hänicke; R Sauter; C Hamburger
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

9.  Perfusion-weighted imaging of peritumoral edema can aid in the differential diagnosis of glioblastoma mulltiforme versus brain metastasis.

Authors:  Osnat Halshtok Neiman; Siegal Sadetzki; Angela Chetrit; Stephen Raskin; Gal Yaniv; Chen Hoffmann
Journal:  Isr Med Assoc J       Date:  2013-02       Impact factor: 0.892

Review 10.  The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives.

Authors:  Patricia Svolos; Evanthia Kousi; Eftychia Kapsalaki; Kyriaki Theodorou; Ioannis Fezoulidis; Constantin Kappas; Ioannis Tsougos
Journal:  Cancer Imaging       Date:  2014-04-29       Impact factor: 3.909

View more
  7 in total

Review 1.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

2.  T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.

Authors:  Bruno-Bernard Rochetams; Bénédicte Marechal; Jean-Philippe Cottier; Kathleen Gaillot; Catherine Sembely-Taveau; Dominique Sirinelli; Baptiste Morel
Journal:  Neuroradiol J       Date:  2017-05-30

Review 3.  Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Ho Sung Kim; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Eur Radiol       Date:  2018-04-04       Impact factor: 5.315

4.  Accuracy of apparent diffusion coefficient in differentiation of glioblastoma from metastasis.

Authors:  Sanaz Beig Zali; Farbod Alinezhad; Mahnaz Ranjkesh; Mohammad H Daghighi; Masoud Poureisa
Journal:  Neuroradiol J       Date:  2021-01-08

5.  Brain Tumor Characterization Using Multibiometric Evaluation of MRI.

Authors:  Faris Durmo; Jimmy Lätt; Anna Rydelius; Silke Engelholm; Sara Kinhult; Krister Askaner; Elisabet Englund; Johan Bengzon; Markus Nilsson; Isabella M Björkman-Burtscher; Thomas Chenevert; Linda Knutsson; Pia C Sundgren
Journal:  Tomography       Date:  2018-03

Review 6.  Mechanisms and Therapy for Cancer Metastasis to the Brain.

Authors:  Federica Franchino; Roberta Rudà; Riccardo Soffietti
Journal:  Front Oncol       Date:  2018-05-24       Impact factor: 6.244

7.  Quantitative MRI using relaxometry in malignant gliomas detects contrast enhancement in peritumoral oedema.

Authors:  I Blystad; J B M Warntjes; Ö Smedby; P Lundberg; E-M Larsson; A Tisell
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.